7 Results for "

α1β1γδ

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "α1β1γδ" in MCE Product Catalog:

Cat. No.: HY-105670
CAS No.: 478149-53-0
Purity:  99.95%
Target:  

nAChR

Research Areas:  

Neurological Disease

PHA-543613 is a potent, orally active, brain-penetrant and selective α7 nAChR agonist with a Ki of 8.8 nM. PHA-543613 displays selectivity for α7-nAChR over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors . PHA-543613 can be used for the cognitive deficits of Alzheimer's disease and schizophrenia research .
loading...
    loading...
Cat. No.: HY-19411
CAS No.: 446031-79-4
Target:  

nAChR

Research Areas:  

Neurological Disease

SSR180711 hydrochloride is an orally active, selective and reversible α7 acetylcholine nicotinic receptor (n-AChRs) partial agonist. SSR180711 hydrochloride can act on rat α7 n-AChR (Ki=22 nM; IC50=30 nM) and human α7 n-AChR (Ki=14 nM; IC50=18 nM). SSR180711 hydrochloride increases glutamatergic neurotransmission, ACh release and long-term potentiation (LTP) in the hippocampus .
loading...
    loading...
Cat. No.: HY-105670B
CAS No.: 478148-58-2
Target:  

nAChR

Research Areas:  

Neurological Disease

PHA-543613 dihydrochloride is a potent, orally active, brain-penetrant and selective α7 nAChR agonist with a Ki value of 8.8 nM. PHA-543613 dihydrochloride displays selectivity for α7-nAChR over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors . PHA-543613 dihydrochloride can be used for the cognitive deficits of Alzheimer's disease and schizophrenia research .
loading...
    loading...
Cat. No.: HY-169870
CAS No.: 107538-05-6
Synonyms: (+)-Mecamylamine; TC-5214
Target:  

nAChR

Research Areas:  

Neurological Disease

Dexmecamylamine ((+)-Mecamylamine) is the antagonist for nicotinic acetylcholine receptor (nAChR), that antagonises the α3β4/α4β2/α7/α1β1γδ receptor with IC50 of micromolare levels. Dexmecamylamine exhibits anxiolytic and antidepressant-like activities .
loading...
    loading...
Cat. No.: HY-105670A
CAS No.: 1586767-92-1
Target:  

nAChR

Research Areas:  

Neurological Disease

PHA-543613 hydrochloride is an oral or active α7 nAChR agonist with brain permeability, For α3β4, α1β1γδ, α4β2 and 5-HT3 receptors selective. PHA-543613 hydrochloride affects sensory gating and memory in an in vivo model of schizophrenia .
loading...
    loading...
Cat. No.: HY-14318
CAS No.: 179120-92-4
Synonyms: SIB-1508Y free base
Target:  

nAChR

Research Areas:  

Neurological Disease

Altinicline (SIB-1508Y free base) is a selective α4β2 nicotinic acetylcholine receptor (nAChR) agonist, with no activity against α7 or α1β1γδ nAChRs and only extremely low activity against α3β4 nAChRs. Altinicline reverses escape deficits and increases avoidance responses. Altinicline is applicable to research related to depression .
loading...
    loading...
Cat. No.: HY-105670R
CAS No.: 478149-53-0
Research Areas:  

Neurological Disease

PHA-543613 (Standard) is the analytical standard of PHA-543613 (HY-105670). This product is intended for research and analytical applications. PHA-543613 is a potent, orally active, brain-penetrant and selective α7 nAChR agonist with a Ki of 8.8 nM. PHA-543613 displays selectivity for α7-nAChR over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors . PHA-543613 can be used for the cognitive deficits of Alzheimer's disease and schizophrenia research .
loading...
    loading...